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Abstract
Previous studies in several different trigeminal nerve injury/inflammation models indicated that the hyperexcitability
of primary afferent neurons contributes to the pain pathway underlying mechanical allodynia. Although multiple
types of voltage-gated ion channels are associated with neuronal hyperexcitability, voltage-gated K
+ channels (Kv)
are one of the important physiological regulators of membrane potentials in excitable tissues, including
nociceptive sensory neurons. Since the opening of K
+ channels leads to hyperpolarization of cell membrane and a
consequent decrease in cell excitability, several Kv channels have been proposed as potential target candidates for
pain therapy. In this review, we focus on common changes measured in the Kv channels of several different
trigeminal neuropathic/inflammatory pain animal models, particularly the relationship between changes in Kv
channels and the excitability of trigeminal ganglion (TRG) neurons. We also discuss the potential of Kv channel
openers as therapeutic agents for trigeminal neuropathic/inflammatory pain, such as mechanical allodynia.
Introduction
Pain caused by a lesion of the peripheral or central ner-
vous system is commonly termed neuropathic pain, and
this type of pain frequently persists, even following nor-
mal repair of the injured tissue [1-3]. In a clinically sig-
nificant proportion of cases, the neuropathic pain
becomes chronic, severely debilitating, and extremely
difficult to treat. Although several different types of neu-
ropathic pain animal models have been developed and
extensively studied [4,5], no common therapeutic mole-
cular target has been identified for neurons located in
the nociceptive pathway.
Multiple types of voltage-gated ion channels are asso-
ciated with neuronal excitability. Among these, voltage-
gated K
+ (Kv) channels are important physiological reg-
ulators of membrane potentials, action potential shape,
and firing adaptation in excitable tissues including noci-
ceptive sensory neurons [6-8]. Dorsal root ganglion
(DRG) and trigeminal ganglion (TRG) neurons
expressed three distinct classes of K
+ currents in varying
quantities: slow-inactivating sustained (K-current; IK),
fast-inactivating transient (A-current; IA), and slow-inac-
tivating transient (D-current; ID) currents based on their
inactivation of kinetics and sensitivities to tetraethylam-
moniun (TEA), 4-aminopyridine (4-AP) and a-dendoro-
toxin (a-DTX), respectively [9-13]. Peripheral nerve
injury and inflammation markedly reduces the densities
of Kv channels, implicating them in the development of
neuropathic/inflammatory pain [14-17]. Since the open-
ing of K
+ channels leads to hyperpolarization of cell
membrane and a resultant decrease in cell excitability,
several types of Kv channels have been proposed as
potential target candidates for such pain pathways [18].
Recent studies in various pain models identified the vol-
tage-gated KCNQ/Kv7 channel (M-current) opener
[19-21] and alterations in either calcium-activated (KCa)
or ATP-sensitive potassium (KATP) channels as potential
therapeutic targets for neuropathic/inflammatory pain
[22,23].
We recently reported on the hyperexcitability of pri-
mary afferent neurons in several different trigeminal
nerve injury and inflammation animal models, including
chronic constriction nerve injury (CCI), axotomy, and
inflammatory models [17,24-26]. In these models, we
systemically investigated the mechanism of mechanical
allodynia underlying changes in the TRG neuronal
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any medium, provided the original work is properly cited.excitability due to several types of neuropathic/inflam-
matory conditions in rats, using behavioral analysis as
well as extracellular single-unit and whole-cell patch-
clamp recordings.
This review therefore focuses on changes in the Kv
channels studied in different trigeminal neuropathic/
inflammatory pain animal models, and particularly the
relationships between Kv channels and TRG neuron
excitability. We also discuss potential therapeutic targets
identified thus far for the prevention of pathological
pain, such as those targeting mechanical allodynia.
Pathological pain models
Peripheral nerve injury/inflammation produces sensory
abnormalities associated with chronic pain. Peripheral
tissue inflammation can alter the property of somatic
sensory pathways, resulting in behavioral hypersensitivity
due to the increased responses to pain caused by nox-
ious stimulation (hyperalgesia) as well as the normally
non-noxious stimulation (allodynia). Several different
types of animal nerve injury models have been devel-
oped to elucidate the neuronal mechanisms underlying
these abnormal pain sensations (allodynia and hyperal-
gesia) [27-29]. Among these models, the CCI model
shows inflammation and nerve injury, and can mimic
neuropathic pain in human [27,30]. CCI of the sciatic
nerve is indeed one of the most reliable models of neu-
ropathic pain [31]. Following peripheral nerve injury,
primary afferent neurons exhibit high frequency back-
ground activity or irregular burst discharges [27]. On
the other hand, in the axotomy of primary afferent neu-
ron model (axotomy model), the hyperexcitability of pri-
mary afferent neurons induced by peripheral nerve
injury is thought to result from extensive changes in the
ionic currents of DRG neurons [32,33]. Moreover,
changes in the excitability of primary afferent neurons
were also observed at the adjacent intact primary affer-
ent neurons after nerve injury (axotomy spared neuron
models) [34,35].
Any discussion of trigeminal neuropathic pain should
consider the following points. First, the trigeminal nerve
has some unique characteristics that may influence its
response to injury, such as its embryological origin, and
the proportion of myelinated and unmyelinated nerves,
and sympathetic fibers [36-38]. In addition, the location
of some branches of the nerve within bony canals pro-
tects them from exogenous stimuli, but makes them vul-
nerable to pressure (e.g., edema or displacement of
fractured bone fragments) [36]. To elucidate the
mechanism underlying trigeminal mechanical allodynia
in different neuropathic pain/inflammatory models, we
recently investigated four such animal models, as
described in the following sections.
Changes in potassium currents and trigeminal
neuropathic and inflammatory pain
Figure 1 summarizes the changes in TRG neuronal
excitability associated with the changes in Kv channels
using whole-cell patch-clamp recording in our trigem-
inal neuropathic/inflammatory pain animal models
[17,24-26]. In each animal model, mechanical allodynia
was determined by withdrawal threshold for the
mechanical stimulation of the whisker pad area.
CCI-model
Trigeminal nerve has a predominant sensory function
compared with that of other peripheral nerves such as
sciatic nerve because it is predominantly composed of
sensory afferents, and only contains a small number of
efferent fibers. It can be assumed that the infraorbital
nerve (ION) does not contain any motor fibers, thus the
trigeminal CCI model provides evidence to demonstrate
the neuropathic pain mechanism following a purely sen-
sory nerve injury [25]. In our study, mechanical allody-
nia appeared at three days after ION-CCI and lasted for
14 days. Whole-cell patch-clamp recordings from med-
ium-/large-diameter CCI-TRG neurons revealed that
both IK and IA in rats with ION-CCI were significantly
smaller than in naïve rats (Figure 1A). Changes in the
duration of the depolarization phase (DDP) and repolar-
ization phase (DRP) contribute to the IA and IK, respec-
tively [12], thus suppression of these current in TRG
neurons following CCI correlated with a decrease in
DDP and an increase in DRP, respectively. Also, the
TRG neuronal action potentials (and consequently, the
total action potential duration) in rats with ION-CCI
were significantly prolonged than those in naïve rats.
Under current-clamp experiments, TRG neurons follow-
ing ION-CCI showed a significant decrease in threshold
currents for generating spike and a depolarizing effect of
resting membrane potentials. In addition, depolarizing
pulses following ION-CCI significantly increased the
discharge frequencies of the TRG neuronal action
potentials. These changes in medium-/large-diameter
CCI-TRG neurons could contribute to the development
of mechanical allodynia.
Axotomy-spared neuron model
Uninjured TRG neurons show similar alterations to
adjacent TRG neurons following injury [24,34]. In this
same model, we found that mechanical allodynia in the
territory of ION was observed at 3 days after inferior
alveolar nerve (IAN) transection. As shown in Figure
1B, voltage-clamp recording indicated that both IK and
IA in the medium-/large-diameter spared (uninjured)
TRG neurons innervating second branches of the tri-
geminal nerve (ION) in rats with IAN were significantly
smaller than those in naïve rats, as for the CCI model.
Corresponding with these changes, we also measured
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Page 2 of 8Figure 1 Trigeminal neuropathic/inflammatory pain models and changes in TRG neuronal activities. A: Chronic constriction nerve injury
(CCI) model. Three days after infraorbital nerve (ION) chronic constriction. Target trigeminal ganglion (TRG) neurons were labeled by fluorogold
(FG). Whole-cell patch-clamp recordings under current-/voltage-clamp configurations were performed on medium/large-diameter CCI neurons. B:
Axotomy-neighboring neuron model. In this model, we found mechanical allodynia in the territory of ION at 2 days after inferior alveolar nerve
(IAN) transection. Uninjured TRG neurons innervating the territory of ION were labeled by FG and patch-clamp recordings under current-/
voltage-clamp configuration was performed on medium-/large-diameter neurons. C: Axotomy-regenerated neuron model. In this model, we
observed mechanical allodynia at 14 days after IAN transection. FG-injection at 14 days after IAN transection showed massive labeling of
trigeminal ganglion containing FG-labeled small/large-diameter neurons and the patch-clamp recordings under current-/voltage-clamp
configuration indicated axotomy-regenerated neurons. D: Inflammation model. Inflammation was induced by injection of CFA into the rat
temporomandibular joint (TMJ). We found mechanical allodynia in the territory of ION at 2 days after CFA injection. In FG-labeled small-diameter
TRG neurons innervating TMJ, the whole-cell patch-clamp recordings under current-/voltage-clamp configurations were performed on
inflammatory neurons. Blackened circles indicate the trigeminal ganglion neurons. I-III: trigeminal nerves, IA: transient K current, IK: sustained K
currents, ↑: increase, ↓: decrease, ▼: tendency for decrease in IK, but not significant, ▲: tendency for depolarization of membrane potential (Vm),
but not significant, Depo: Depolarization, V-clamp : Voltage-clamp, I-clamp: Current-clamp.
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1) frequencies of the spike discharge induced by depo-
larizing pulses and duration of uninjured TRG neurons
in rats with IAN were significantly increased; and 2) sig-
nificant decrease in threshold current for generation of
spike and a depolarizing effect of resting membrane
potentials of spared TRG neurons after IAN transection.
These changes of medium-/large-diameter spared TRG
neurons might contribute to the development of
mechanical allodynia through paracrine signaling (e.g.,
brain-derived neurotrophic factor) from adjacent injured
TRG neurons [24].
Axotomy-regenerated neuron model
Injured nerves regenerate several weeks after nerve
damage [39-41]. Some clinical reports have noted that
areas innervated by the regenerated nerve show an
altered sensitivity to a variety of stimuli compared to
t h o s ei n n e r v a t e db yt h ei n t a c tn e r v ea c t i v i t y[ 4 2 - 4 5 ] .
The regenerated neurons also exhibit ectopic discharges
[46,47]. Recently we investigated the neural mechanisms
underlying abnormal pain following regeneration of the
injured IAN [26]. In this model, we observed mechanical
allodynia at 11-14 days after IAN transection. Injection
of the retrograde tracer, fluorogold (FG), at 14 days
after IAN transection showed extensive labeling of TRG
neurons, suggesting that most of the TRG neurons pre-
sent at that stage were regenerated. Whole-cell patch-
clamp recording of FG-labeled small-/medium-diameter
reinnervated TRG neurons showed a significant decrease
in both IA and IK i nt h eT R Gn e u r o n s ,ar e s p o n s et h a t
was associated with an increase in the spike generation,
resulting in the hyperexcitability of reinnervated IAN-
TRG neurons (Figure 1C). Taken together with previous
results from intracellular single-unit recording [26],
these changes may be due to the mechanical allodynia.
Inflammation-model
Complete Freund’s adjuvant (CFA) models of inflamma-
tion in the orofacial region have been developed in rats
to study the trigeminal nervous system [48,49]. Tempor-
omandibular joint (TMJ) inflammation is associated
with spreading pain and hyperalgesia [50] and TMJ dis-
order paitients complain of pain from innoxious vibro-
tactile stimulation [51]. We recently reported that TMJ
inflammation modulates the excitability of Ab-TRG
neurons innervating the facial skin via a paracrine
mechanism due to the release of substance P (SP) from
the small-diameter TRG neurons. Such a release may be
important in determining the trigeminal inflammatory
allodynia associated with TMJ disorders [52,53]. Using
this TMJ inflammatory model, we found that mechani-
cal allodynia in the whisker skin region and IA densities
in the small-diameter TRG neurons innervating TMJ
were both significantly decreased in inflamed rats com-
pared to naïve rats [17]. TMJ inflammation significantly
reduced the threshold current and significantly
increased action potential firing evoked by depolarizing
current pulses. In this model there is a tendency for
decreases in IK density in TMJ inflamed rats compared
to naïve rats, although the change is not significant.
Since application of 4-aminopyridine (A-type K channel
blocker) to naïve rats TRG neurons mimicked the
changes in the firing properties observed after CFA
treatment [17], IA suppression of the TRG neurons
innervating the TMJ could affect trigeminal inflamma-
tory allodynia in TMJ disorders via paracrine mechan-
isms of SP in the trigeminal ganglia.
Potassium channels as a potential target for trigeminal
neuropathic/inflammatory pain
Lawson et al. [18] reported that several types of Kv
channels have been proposed as potential target candi-
dates for pain therapy. It was recently demonstrated
that a selective KCNQ/Kv7 channel opener (retigabine),
which mediates M-currents, selectively reduces the
activity of axotomized Aδ/C-fibers, but not uninjured
axons [19], and human C-fiber axons [21]. Xu et al. [20]
also demonstrated that this KCNQ/Kv7 channel opener
could attenuate allodynia due to TMJ inflammation in
rats. Similarly, axotomy reduces KCa channel activity in
the small to medium sized DRG neurons, which would
also increase membrane excitability [21]. Thus, these
channels may be involved in the development of hyper-
algesia and allodynia. On the contrary, spinal nerve liga-
tion suppressed KATP channels only in large-diameter
neurons, but not in small-diameter neurons, from
hyperalgesic rats [23].
As described in the preceding chapter, experiments in
our trigeminal neuropathic/inflammatory pain model
indicated that the common changes in the Kv channels,
such as IA,I K in rats with neuropathic/inflammatory
pain, were significantly suppressed compared to those in
naïve rats. Since previous reports suggested that IA and
IK are important for regulating the firing frequency and
duration of action potentials in the TRG neuron, respec-
tively [12,13], these Kv changes caused an incremental
spike discharge and prolongation of duration of action
potentials in the neuropathic/inflammatory pain rats.
The relationship between depression of Kv and excit-
ability of TRG neurons under trigeminal neuropathic/
inflammatory pain conditions are summarized in Figure
2. It is well established that the duration of action
potentials in primary afferents influences the amount of
neurotransmitter released from the soma and the per-
ipheral and central terminals [10,11]. Increased action
potential duration and firing frequencies prolong the
opening of voltage-gated Ca
2+ channels, probably poten-
tiating Ca
2+ influx and causing an increase in the neuro-
transmitter released from the cell bodies and/or
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enhancing the amount of neurotransmitter released
from central terminals probably contributes to the
hyperexcitability of second-order nociceptive and wide
dynamic-range neurons in the trigeminal spinal nucleus
neurons (central sensitization) [24,25,49-54]. In addition,
increasing the neurotransmitters/neuromodulators (e.g.,
SP) released from the cell body of TRG neurons through
a paracrine or autocrine mechanism may activate the
neighboring TRG neurons [52,53]. Since previous stu-
dies suggested that peripheral inflammation can depolar-
ize trigeminal satellite-glial cells via activation of
neurokinin 1 receptor (SP release from small diameter
TRG neurons) [55,56], such changes may further pro-
mote the interaction between satellite-glial cells and
TRG neurons associated with pathological pain within
the trigeminal ganglia [55-57].
The precise mechanism by which Kv depression of
TRG neurons affects the neuropathic/inflammatory con-
dition remains to be determined. Recent studies demon-
strated that small- to medium-diameter TRG neurons
express glial cell line-derived neurotrophic factor
(GDNF) and its receptor components, such as GFRa1
[58,59]. To this end, we recently found that acute
Figure 2 Relationship between depression of Kv and excitability of TRG neurons under trigeminal neuropathic/inflammatory
conditions. A: The operational component of primary sensory neurons (1
st) includes a peripheral terminal that innervates target tissues and
transduces sensory stimuli. An axon conducts action potentials from the periphery to the central nervous system via the cell body in the
trigeminal ganglion and central terminal, from where information is transferred to second order neurons (2
nd) at the central synapse (e.g.,
trigeminal spinal nucleus). B: The relationship between the depression of Kv channels and the excitability of TRG neurons. The increases in action
potential firing and duration prolongs the opening of voltage-gated Ca
2+ channels (Cav), potentiating Ca
2+ influx, and causing an increase in
neurotransmitter released from the cell bodies and nerve terminals. These changes can alter the properties of trigeminal pain pathways.
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of adult rat small-diameter TRG neurons, which inner-
vate the facial skin in the absence of neuropathic and
inflammatory conditions [60]. This potentiation of
small-diameter TRG neuronal excitability is mediated by
inhibition of Kv channels, and transection of sciatic
nerve in rat upregulated the expression of GDNF and
GFRa-1 mRNA in the proximal nerve trunk [61,62].
Thus, GDNF-induced potentiation of sensory neuronal
excitability may account for enhanced pain sensitivity,
resulting from increased levels of GDNF after tissue
injury, and further studies are needed to elucidate possi-
ble mechanisms underlying this effect.
Finally, opening of K
+ channels leads to hyperpolariza-
tion of the cell membrane, and a resultant decrease in
cell excitability. We thus propose the potential develop-
ment of IK and/or IA channel openers as therapeutic
agents for preventing trigeminal neuropathic pain, such
as mechanical allodynia. Kv channel subunits, Kv2.1 and
Kv2.2, contribute to the IK channel and play a distinct
role in regulating neuronal excitability [63,64]. However,
Kv1.4 and 4.1-4.3 channels may also be involved in
forming A-type Kv channels in sensory neurons [65-67].
Among these Kv channel a subunits, Kv1.4, 2.2, and 4.2
mRNAs are downregulated under neuropathic condi-
tions involving the transection and CCI of sciatic nerves
[15,16]. Rasband et al. [65] demonstrated that Kv1.4 is
t h es o l eK va subunit expressed in smaller diameter
DRG neurons, and not Kv4-family channels. Since the
pharmacology and gating properties of DRG A-type Kv
channels are similar to those of heterogeneously
expressed Kv4 channels [66,67], we could not comple-
tely rule out a potential role for Kv4.1, 4.2, and 4.3 in
neuropathic pain. Previously, we reported that TMJ
inflammation decreased the expression of Kv1.4 subu-
nits in small-/medium-diameter (Aδ-/C-) TRG neurons
and that this may contribute to trigeminal inflammatory
allodynia associated with TMJ disorders [68]. Nerve
injury also induces accelerated reduction in Kv 1.4
expression in the small-diameter nociceptive DRG neu-
rons [65]. Taken together, these findings suggest Kv 1.4
channel as candidate molecular targets, and further stu-
dies are needed to explore this possibility.
Conclusion
Several different animal models of trigeminal nerve
injury/inflammation showed depression of both IA and
IK in TRG neurons, compared to naïve rats. These com-
mon changes contribute to the incremental spike dis-
charge and action potential prolongation in these
neurons, and may alter the properties of trigeminal pain
pathways. Our results therefore would suggest that Kv
channel (IA and IK) openers have potential as
therapeutic agents against trigeminal neuropathic/
inflammatory pain, such as mechanical allodynia.
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